News and Opinion
May 19, 2021
COVID-19 vaccines dose-sharing and surged production can protect the world’s population, says IPHA Industry urges partnership in the effort to equitably vaccinate all priority populations globally […]
May 6, 2021
Biopharmaceutical industry urges Government to oppose ‘ineffectual’ IP waiver proposal Waiving IP rights would not boost global production for COVID-19 vaccines, says IPHA Ireland’s international originator […]
April 26, 2021
Public appetite for COVID-19 vaccine rises to 85%, says Ipsos MRBI tracker survey for IPHA Just 6% of people would refuse a COVID-19 vaccine, a consistent […]
April 25, 2021
IPHA Consumer Healthcare Division rebranded as Self-Care Division Renewed emphasis on building trust in self-care through access, awareness and education, reducing the burden on the healthcare […]
March 29, 2021
How much value do innovative medicines generate for the economy? by Bernard Mallee More than a year since the World Health Organisation declared Covid-19 a pandemic, […]
March 25, 2021
New medicines generate €52bn in socioeconomic value for Ireland, says WifOR study for IPHA Ground-breaking analysis shows more than 1.4m fewer years of life are lost […]
February 28, 2021
IPHA urges IP protection as world marks Rare Disease Day The Irish Pharmaceutical Healthcare Association (IPHA) has urged industry and policymakers to work together to protect […]
February 24, 2021
Just 6% of people will refuse COVID-19 vaccine, says Ipsos MRBI tracker survey for IPHA More than three in four people will get immunised against the […]
February 8, 2021
€30m released for ‘backlogged’ medicines at same time as industry agrees new Agreement extension Patients to benefit from wider range of innovative treatment options under ‘bridging’ […]